BioSpace News Archive

Agenus Inc.. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced today receipt of a cash milestone from Incyte for the initiation of a Phase 1 clinical trial of INCAGN2385, an anti-LAG-3 antibody discovered by Agenus.

Today, VisualDx, the leading diagnostic clinical decision support tool for physicians, unveiled its first app geared at consumers,

This September, National Honey Month will be a little “sweeter” as the Bayer Bee Care Program kicks off several efforts to raise awareness of current initiatives to improve pollinator health.

Beam, the first pay-as-you-scale digital health app helping small medical practices easily bill insurance for the virtual care they deliver, as well as attract and retain busy patients, launched for doctors today at Health 2.0.

Biobright is building tools for the smart laboratory of the future that will automate data collection and analysis to help scientists carry out more reproducible experiments.

MIACH Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced today it completed $22.5 million in financing.

TRIMEDX to accelerate growth as an independent provider-driven clinical asset management organization

Nemaura Pharma today announced it has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.

Premier Protein - a line of shakes, powders, bars and Clear drinks known for their delicious taste and best-in-class nutritionals - has announced the launch of new Earth First packaging for its ready-to-drink shakes.

Pulmatrix, Inc. will present preclinical data on the anti-inflammatory activity of PUR1800 (RV1162) at the ERS International Congress 2018.